Neil K. Warma - 08 Oct 2024 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PMN	Option (right to buy)	Award	$0	+1,144,122	+549%	$0.000000	1,352,455	08 Oct 2024	Common Shares	1,144,122	$1.15	Direct	F1
transaction	PMN	Option (right to buy)	Award	$0	+490,338	+36%	$0.000000	1,842,739	08 Oct 2024	Common Shares	490,338	$1.15	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Initial Award is 25% vested upon grant with the remaining shares vesting ratably over thirty-six months
F2	Performance Award shall vest 25% on the date that the 10-day VWAP of the Common Shares on the Nasdaq Capital Market exceeds three times the exercise price, $3.45, with the remainder vesting ratably over the following thirty-six months